Adverse events reported in ≥ 10% and 3 – 10% of patients receiving winstrol vin combination with cyclosporine and corticosteroids after transplantation of kidney, heart and liver. The body generally ≥ 10%:asthenia, fever, headache, infection, pain ( in the abdomen, lower back, chest), peripheral edema, sepsis, ascites, abdominal distension, hernia, peritonitis, hiccups. 3 – 10%: cyst (including lymphocele and hydrocele), facial swelling, flu-like symptoms, bleeding, hernia , malaise, pelvic pain, cellulite, neck pain, pale skin. blood system and lymphatic system ≥ 10%: . anemia (including hypochromic), leukocytosis, leukopenia, thrombocytopenia, ecchymosis 3 – 10%: ecchymosis , polycythemia, petechiae, increased prothrombin and thromboplastin time, pancytopenia. urinary tract ≥ 10%: hematuria, renal tubular necrosis, urinary tract infection, renal dysfunction, oliguria. 3 – 10%: albuminuria, dysuria, hydronephrosis, impotence, pyelonephritis, frequent urination, hematuria, nocturia, renal impairment, incontinence, and urinary retention; acute renal failure, scrotal edema.
Cardiovascular system ≥ 10%: hypertension, arrhythmia, bradycardia, cardiac failure, hypotension, pericardial effusion. 3 – 10%: angina, hypotension, including orthostatic, tachycardia, bradycardia, thrombosis, syncope, vasodilatation; arrhythmias (supraventricular and ventricular premature beats, shimmering, and atrial flutter, supraventricular and ventricular tachycardia), heart failure, congestive heart failure, pulmonary hypertension, vasospasm, increased venous pressure.
Metabolism ≥ 10%: acidosis (metabolic or respiratory), body weight gain , hypervolemia; . violation of wound healing 3 – 10% after kidney transplantation: acidosis (metabolic or respiratory), body weight gain, dehydration, hypervolemia, gout, hypovolemia, hypoxia, thirst, weight loss, alkalosis. Laboratory values ≥ 10%: hyperglycemia, hyperkalemia, hypokalemia , hypophosphatemia; hyperbilirubinemia, increased residual nitrogen, increased creatinine, increased activity of enzymes winstrol vin serum, hypercholesterolemia, hyperlipidemia, hyperuricemia, hypomagnesemia, hyponatremia; hypocalcemia, hypoproteinemia. 3 – 10%: increase in the activity of alkaline phosphatase, gamma-glyutamiltrans peptidase, in blood serum, increased serum creatinine, hypercalcemia, hyperlipidemia, hypocalcemia, hypoglycemia, hypoproteinemia, hyperuricemia, hyposalemia, hypophosphatemia; . hyponatraemia Gastrointestinal:> 10%: dyspepsia, vomiting, constipation, diarrhea, oral candidiasis, cholangitis, cholestatic jaundice, hepatitis, anorexia. 3 – 10%: dysphagia, gingivitis, gingival hyperplasia, stomatitis, esophagitis, gastritis, gastroenteritis, gastrointestinal bleeding, stomach ulcers, intestinal bleeding, intestinal obstruction, melena, rectal damage, candidiasis of the gastrointestinal tract. respiratory ≥ 10%: increased cough, dyspnea, pharyngitis, pneumonia, bronchitis; bronchial asthma, pleural effusion, rhinitis, sinusitis; atelectasis. 3 – 10%: asthma, pleural effusion, pulmonary edema, rhinitis, sinusitis, sleep apnea, atelectasis, bronchitis, epistaxis, hemoptysis, neoplasm, pneumothorax, pulmonary edema, increased sputum, change of voice, hyperventilation, candidiasis of the respiratory tract, . rhinitis skin and appendages ≥ 10%: acne, herpes simplex, herpes zoster, rash, pruritus, increased sweating. 3 – 10%: hair loss, benign skin tumors, fungal dermatitis, herpes simplex, herpes zoster, hirsutism, pruritus, skin cancer, skin hypertrophy, sweating, skin ulcer, rash, sweating, acne, bleeding, herpes zoster, hirsutism, benign skin tumors, skin ulcers, vesicles-bullous rash. Nervous system ≥ 10%: dizziness, insomnia, tremor; agitation, anxiety, confusion, depression, hypertonia, paresthesia, somnolence, tremor. 3 – 10%: agitation, depression, hypertonia of the winstrol vskeletal muscles, paresthesia, drowsiness; convulsions, emotional lability, hallucinations, neuropathy, decrease mnemonic, dizziness; delirium, dry mouth, neuropathy, psychosis, abnormal thinking.